BOUCHARA-RECORDATI, FRANCE
Bouchara-Recordati S.a.s. offers pharmaceutical specialities in many therapeutic areas such as anti-infectives, the central nervous system and nutritional support. The company was founded in 2001 and is based in France. Bouchara-Recordati S.a.s. operates as a subsidiary of Recordati S.p.A.
Recordati S.p.A., established in 1926, is an international pharmaceutical group with a total staff of more than 4,100, dedicated to the research, development, manufacturing and marketing of pharmaceuticals. Headquartered in Milan, Italy, Recordati has operations in many countries throughout the world. An efficient field force of medical representatives promotes a wide range of innovative pharmaceuticals, both proprietary and under licence, in a number of therapeutic areas. Recordati is a partner of choice for new product licenses for its territories and is committed to the research and development of new specialities with a focus on treatments for rare diseases.
We currently distribute the following products from Bouchara-Recordati.
Calperos chewable calcium tablet contains 1250 mg of calcium carbonate (equivalent to 500 mg of elemental calcium) in each tablet.
Calcium is the most abundant mineral in the human body and is essential for maintaining bone and dental health. It also contributes to normal heart, muscle and nerve functions.
Calperos is administered by chewing the tablet before swallowing, hence allowing for an increased rate of absorption and better absorption of the ingested calcium carbonate.
Active Ingredients:
- Dexamethasone sodium metasulfobenzoate
- Neomycin sulfate
- Polymyxin B sulfate
Indications:
- Otitis externa with an intact tympanum, particularly infected eczema of the external auditory meatus
- Incised acute otitis media
Active Ingredient:
- Vitamin D3 (Cholecalciferol)
Indications:
- Treatment and/or prevention of vitamin D-deficiency states
